Product Liability

January 19, 2017

Stryker Metal Hip Failure, Recall and Lawsuits

Metal on metal hip implants have been around for the past two decades but they have been plagued with early failure, metal poisoning, tissue destruction and finally the need for painful replacement surgery.

Metal on metal hip implants have a high failure rate including those manufactured by Biomet, DePuy, Encore, Smith & Nephew, Stryker, Wright and Zimmer.

Now Howmedica Osteonics and its subsidiary Stryker have the dubious honor of being the latest metal on metal hip manufacturer to join the metal hip failure rogues gallery.

January 17, 2017

IVC Filter Injury and Death lawsuits pass 3,000

by Dr. Shezad Malik

The number of Inferior Vena Cava (IVC) filter injury and death lawsuits continue to climb and now are past the 3,000 mark over design defects leading to fractures, migration, tilting and perforation.

Recent medical studies have linked IVC filters to serious and catastrophic injuries.

What are IVC Filters?

January 13, 2017

DePuy Pinnacle Metal on Metal Hip Texas Trial

by Dr. Shezad Malik

DePuy Pinnacle metal on metal hip Texas trial update. A federal jury in Dallas recently ordered Johnson & Johnson (J&J) and its DePuy Orthopaedics subsidiary unit to pay more than $1 billion to six plaintiffs who claimed that they were injured by their line of Pinnacle metal on metal hip implants.

The jurors found that the Pinnacle hip implants were defectively designed and that the companies failed to warn patients about the risks of serious complications including metallosis (metal poisoning) and the early failure of these devices.

DePuy Pinnacle Metal on Metal Hip 9,000 Federal Lawsuits and counting

January 12, 2017

Talcum Powder Ovarian Cancer 2017 Update

by Dr. Shezad Malik

I am providing this timely update for women who have succumbed to talcum powder linked ovarian cancer .

Talcum Powder linked to Ovarian Cancer link

Talcum powder ovarian cancer. Medical research and jurors have found talcum powder ovarian cancer link.

Talcum Powder Ovarian Cancer link

December 9, 2016

Atrium C-Qur Hernia Mesh Lawsuit claim repair patch Injuries

by Dr. Shezad Malik

Atrium C-Qur Mesh hernia mesh lawsuits claim repair patch injuries, according to allegations in many personal injury and product liability lawsuits. There are several Atrium C-Qur hernia mesh lawsuits filed in federal courts nationwide.

Atrium C-Qur Hernia Mesh Injury Lawsuits

Atrium C-Qur hernia mesh lawsuits claim repair devices are linked to abdominal injuries, infections and allergic reactions.

Kentucky Atrium C-Qur Hernia Mesh Lawsuit

In a recently filed lawsuit in the U.S. District Court for the Western District of Kentucky, Kent Simmons alleges that he developed severe abdominal pain and mesh exposure after an Atrium C-Qur patch was implanted for hernia repair.

According to Simmons, the hernia mesh product was defectively designed and unreasonably dangerous. Simmons underwent hernia surgery in October 2015, and then he needed further surgery to remove the Atrium C-Qur hernia mesh, after it damaged his abdominal wall.

What is Atrium C-Qur Hernia Mesh? Continue reading

October 29, 2016

Talcum Powder causes Ovarian Cancer?

by Dr. Shezad Malik

Talcum Powder causes Ovarian Cancer? Depends on who you ask. According to Johnson and Johnson the maker of their flagship baby powder product and their follow up product, Shower to Shower, the answer is a resounding NO!

Talcum Powder causes Ovarian Cancer link

Medical research and jurors have found talcum powder ovarian cancer link.

But the jury asked to sit and weigh through the evidence presented in the third bellwether trial to take place in St. Louis would disagree vehemently.

October 28, 2016

St. Louis $70M Talcum Powder Ovarian Cancer Verdict

by Dr. Shezad Malik

A St. Louis jury yesterday announced a $70 million talcum powder ovarian cancer verdict, in the third talcum powder ovarian cancer case to go to trial.

Medical research and jurors have found talcum powder ovarian cancer link.

Deborah Giannecchini, 62, used Johnson & Johnson’s (J&J) baby powder for feminine hygiene for more than four decades until her diagnosis with ovarian cancer three years ago.

Giannecchini has an 80 percent chance of dying in the next two years, and has undergone surgery, radiation and chemotherapy.

J&J and Imerys Hammered

A J&J unit was ordered to pay $65 million in punitive damages and 90 percent of about $2.5 million for medical costs and pain and suffering.

Co-defendant Imerys Talc America, the supplier of the talc, was hit with $2.5 million in punitive damages.

Juror: “J&J Didn’t Care”

As reported in Bloomberg News, the company should have provided a warning label on the product to let consumers decide whether to use talc, one juror Billie Ray, 76, of St. Louis, said after the trial. “It seemed like Johnson & Johnson didn’t pay attention,” she said. “It seemed like they didn’t care.”

October 28, 2016

$70 M J&J Talcum Powder Ovarian Cancer Verdict

by Dr. Shezad Malik

A St. Louis jury yesterday awarded over $70M to a woman injured in Johnson & Johnson talcum powder ovarian cancer lawsuit.

Medical research and jurors found talcum powder Ovarian Cancer link.

Deborah Giannecchini of Modesto, California was awarded more than $70 million in her lawsuit alleging that years of using Johnson & Johnson’s baby powder made with talc caused her ovarian cancer.

October 26, 2016

Louisiana Taxotere Hair Loss lawsuit filed

by Dr. Shezad Malik

Another Louisiana Taxotere hair loss lawsuit has been filed. The lawsuit was filed in the U.S. District Court for the Eastern District of Louisiana against Sanofi-Aventis over the failure to warn about the side effects of Taxotere.

According to Iris Guidry, in her Louisiana Taxotere hair loss lawsuit, claims that the chemotherapy drug Taxotere caused her to suffer permanent and horrendous hair loss, which is not associated with other effective breast cancer treatments.

Guidry claims that Sanofi-Aventis withheld critical information and warnings from patients and doctors about the risk that patients may experience permanent hair loss from Taxotere.

Hair Loss is common after Chemotherapy

Temporary hair loss is to be expected after chemotherapy, and the drug manufacturer claimed that hair grows back after Taxotere use. But, Guidry alleges that since she received breast cancer treatments involving Taxotere in 2011, she has continued hair loss side effects.

Taxotere Hair Loss Lawsuits

Many Taxotere failure to warn lawsuits are filed across the U.S., claiming that Sanofi-Aventis did not adequately disclose the risks of permanent and horrendous hair loss, providing reckless marketing statements. The lawsuits also claim that the drug manufacturer actively encouraged doctors to use Taxotere despite its risks and despite the availability of other, safer cancer treatments.

October 25, 2016

Bard IVC Filter Injury lawsuits heading to trial in 2017

by Dr. Shezad Malik

The Bard IVC Filter Injury lawsuits heading to trial set for 2017, according to the U.S. District Judge presiding over the coordinated pretrial proceedings in Phoenix, Arizona. Judge Campbell ruled that the first “bellwether” trial will probably go before a jury in fall of 2017. Since that date is a year away, more likely than not the date is liable to be moved as the cases get further developed.

Recent medical studies have linked IVC filters to serious injuries and death in severe cases.

Federal Multidistrict Litigation

Lawsuits filed throughout the federal court system over severe and catastrophic complications with Bard inferior vena cava (IVC) filters have been centralized in the U.S. District Court for the District of Arizona, since August 2015.

There are over 1,000 Bard IVC Filter injury lawsuits and wrongful death claims before Judge Campbell. These Bard IVC Filter injury lawsuits have similar claims; that patients suffered serious injuries and on occasion died after receiving a Bard G2, Bard Recovery, Bard Denali, Bard Eclipse, Bard Meridian or other Bard IVC filter for prevention of a pulmonary embolism.

What is the problem with IVC Filters? Continue reading